Exploring opportunities in areas where Novartis has active efforts, such as breast and lung cancers, melanoma, renal cell carcinoma, and malignant hematology; and we seek to expand into other high-unmet need areas such as hepatocellular, pancreatic, colorectal, and prostate cancers and others. Our partnering teams are organized by stage of development (clinical stage or early), tumour type, or biology of the intervention.

Mark Temples portrait

Mark Temples

Breast and Gynaecological (Ovarian, Endometrial).



Ario Arabi Portrait


Ario Arabi

Lung and Melanoma.


Jesus Baena Portrait

Jesus Baena

Solid Tumours GI/GU.




Seeking partners to significantly improve standard of care and cure patients in selected high unmet need in benign hematology diseases. The vision is to transform a number of disease specific classes not limited to hemophilia, complement disorders, anemia, sickle cell disease and thalassemia.

Laura Ripin portrait

Laura Ripin

Leukaemias and Myeloid Dysplastic Syndromes.



Markus Werner portrait

Markus Werner

Lymphomas and Multiple myelomas, CAR-T programs.


Reza Mazhari portrait

Reza Mazhari

Small molecules for Oncology and all pre PoC deals.



Bose Avirup portrait

Avirup Bose

Non Malignant Hemotology (Sickle Cell Disease).